Published OCT 1, 2026

Orlando Med Spa, Injectables-Led Aesthetics Practice with Clinical Team In Place

Orlando, Florida

$596K
SDE
Subscribe Free

Read the full deal writeup

Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is an established Orlando med spa anchored in injectables, which account for more than half of revenue. The practice runs on an experienced clinical bench of three full-time nurse practitioner injectors, one part-time NP injector, and a licensed electrologist, with a stable, returning patient base that drives repeat visits for Botox, fillers, and related aesthetic treatments. Nearly 1,000 Google reviews averaging 4.8 stars signal a genuine local brand and consistent patient satisfaction in a competitive aesthetics market.

The standout structural feature here is that the seller is non-revenue-generating, meaning the practice does not depend on owner production. That is rare in aesthetics, where many sellers are the lead injector and the business collapses on their exit. Here the clinical revenue lives with the W2 providers, which de-risks the transition for a buyer who can retain the team and protect the patient panel.

At $596k of EBITDA with no disclosed asking price or revenue, the headline economics are solid for a service business of this size. The seller is exiting to pursue unrelated business opportunities and has stated a preference for an experienced operator who will protect patients and support providers, which tells you continuity of care and staff retention are the whole game in diligence.

Why we like it

  • Earnings quality is strong for the category: $596k EBITDA generated primarily by salaried clinical providers rather than the owner. Because the seller is non-revenue-generating, the cash flow should largely survive the ownership change, which is the opposite of the typical owner-injector med spa that is really just a job.
  • The injectable mix creates durable, quasi-recurring revenue. Botox and filler patients return on 3 to 4 month cycles by the nature of how the products wear off, so more than 50% of revenue sits in a treatment category that pulls clients back on a predictable clock without re-winning each sale.
  • The aesthetics market has strong secular tailwinds. Demand for injectables has grown steadily across age brackets, Orlando is a large and growing metro, and nearly 1,000 reviews at 4.8 stars shows this practice already owns real local reputation and search visibility.
  • The operator advantage is real for anyone with multi-location or aesthetics experience. A proven team and patient base in place means a buyer can focus on adding devices, memberships, and a second location rather than building clinical capability from scratch.

How to improve it

  • Launch or expand a membership and loyalty program in the first 90 days. Converting the injectable base to prepaid annual plans or monthly memberships smooths cash flow, raises visit frequency, and locks retention ahead of any competitive poaching of providers.
  • Audit and optimize the treatment menu margin. Injectables are over half of revenue, but device-based services (laser, body contouring, microneedling) and skincare retail carry high incremental margin on existing patient traffic, so cross-sell scripting and provider incentives can lift average ticket quickly.
  • Lock in the clinical team with retention agreements before close. The entire thesis rests on keeping three full-time NP injectors and the electrologist, so non-competes, bonus structures, and clear equity-free incentives are a day-one priority, not a later initiative.
  • Tighten digital marketing and lead capture. With almost 1,000 reviews and a 4.8 rating, paid search, Instagram, and a modern booking funnel can convert the existing reputation into measurably more new-patient volume without proportional spend.
  • Add treatment chairs or extend hours to raise utilization. If the providers are near capacity, incremental capacity directly drops to EBITDA; if they are underutilized, filling the schedule is the cheapest growth available.
  • Build a standardized financial and KPI reporting pack. Track revenue per provider, per chair, and per treatment, plus patient retention cohorts, so the operator can manage the practice by numbers and make the asset cleanly sellable at a higher multiple later.
  • Explore a second Orlando-area location using the proven playbook. With a repeatable clinical model and a recognizable brand, a measured second site is the clearest path to turning this single practice into a small platform.

Diligence notes

  • Demand the actual revenue figure and the gross margin bridge to the $596k EBITDA. Revenue is undisclosed, so you cannot assess the multiple, provider cost structure, or product (toxin and filler) spend as a percent of sales without it, and EBITDA alone is not enough to price this.
  • Stress-test provider dependency and retention risk. Confirm each NP injector's patient volume, tenure, compensation, and willingness to stay post-close, because losing even one of three full-time injectors could remove a meaningful slice of that injectable-led revenue.
  • Verify the medical director and regulatory structure. Florida med spas operate under specific supervision and ownership rules for medical practices, so confirm the licensed physician oversight, NP scope-of-practice compliance, and whether the current structure transfers cleanly to a non-clinician buyer.
  • Validate the recurring nature of the patient base with data. Pull repeat-visit rates, patient retention cohorts, and new-versus-returning revenue split to confirm the stable recurring client base claim rather than taking the listing's word for it.
  • Review the lease terms and location economics. Real estate is leased, so confirm remaining term, renewal options, rent escalators, and assignability, since relocation risk would directly threaten the patient base and local search ranking.
  • Scrutinize supplier and pricing exposure on injectables. Understand purchasing agreements, rebate programs, and any volume commitments with toxin and filler manufacturers, as these materially affect margin and are a common hidden lever in aesthetics economics.

Source

Originally listed on BizBuySell. View original listing →

Want the full analysis on every deal? Unlock the complete platform with Accredited Pro to screen live listings and read our operator-level writeups.